Search - tctmd.com

Displaying 541 - 560 of 1726

Sort: Relevancy | Date

Presentation TCT 2018

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Patrick W. Serruys

September 21, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Donald Cutlip

September 21, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Chuck Simonton

September 21, 2018

Presentation TCT 2018

Pulmonary Artery Denervation: Updates of Experimental and Clinical Studies

Presenter: Runlin Gao, Martin B. Leon, Shao-Liang Chen

September 21, 2018

Presentation TCT 2018

Iron-Based BRS: Design Features, Experimental Studies, and FIM Experience

Presenter: Runlin Gao, Martin B. Leon, Kefei Dou

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Platforms and Outcomes 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Gennaro Sardella

September 21, 2018

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

Presentation TCT 2018

What is the Future of Bioresorbable Scaffolds?

Presenter: Jeroen J. Bax, Stephan Windecker, Michael Haude

September 21, 2018

Presentation TCT 2018

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Presenter: Bernardo Cortese

September 21, 2018

Presentation TCT 2018

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Presenter: Azman Wan Ahmad

September 21, 2018

Presentation TCT 2018

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Presenter: Juan F. Granada

September 21, 2018

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

Presentation TCT 2017

Case #13 (With Discussion): Late Scaffold Failure Due to Intraluminal Scaffold Dismantling

Presenter: Hiram G. Bezerra, Nick E. J. West, Daniel Chamie

November 01, 2017

Presentation TCT 2017

Implications of Acute BRS Malapposition (With Case Presentations)

Presenter: Corrado Tamburino, Robert-Jan van Geuns, Yoshinobu Onuma

November 01, 2017

Presentation TCT 2017

Case #12 (With Discussion): An Unusual Case of Scaffold Failure Within 1 Year

Presenter: Hiram G. Bezerra, Nick E. J. West, Niels R. Holm

November 01, 2017

Presentation TCT 2017

Mechanisms and Predictors of BRS Thrombosis After 1 Year (With Case Demonstrations)

Presenter: Corrado Tamburino, Robert-Jan van Geuns, Joanna J. Wykrzykowska

November 01, 2017

Presentation TCT 2017

State-of-the-Art Review: Bioresorbable Vascular Scaffolds Practical Lessons Learned From Intravascular Imaging About Failure Modes and Optimal Deployment

Presenter: Hiram G. Bezerra, Nick E. J. West, Hector M. Garcia-Garcia

November 01, 2017

Presentation TCT 2017

Mechanisms and Predictors of BRS Restenosis (With Case Demonstrations)

Presenter: Corrado Tamburino, Robert-Jan van Geuns, Daniel Chamie

November 01, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

Presenter: Martin B. Leon, Marco Valgimigli, Giulio G. Stefanini

November 01, 2017

Advertisement

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

The Methods for Coronary Stent Development

The Methods for Coronary Stent Development

Pulmonary Artery Denervation: Updates of Experimental and Clinical Studies

Iron-Based BRS: Design Features, Experimental Studies, and FIM Experience

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

What is the Future of Bioresorbable Scaffolds?

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Case #13 (With Discussion): Late Scaffold Failure Due to Intraluminal Scaffold Dismantling

Implications of Acute BRS Malapposition (With Case Presentations)

Case #12 (With Discussion): An Unusual Case of Scaffold Failure Within 1 Year

Mechanisms and Predictors of BRS Thrombosis After 1 Year (With Case Demonstrations)

State-of-the-Art Review: Bioresorbable Vascular Scaffolds Practical Lessons Learned From Intravascular Imaging About Failure Modes and Optimal Deployment

Mechanisms and Predictors of BRS Restenosis (With Case Demonstrations)

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Appreciation and Critique

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content